Tue, Mar 4, 1:50 PM, Zacks
Myriad Genetics Up on Prolaris Data; Aims Reimbursement - Analyst Blog
Recently, favorable data from Myriad Genetics PROCEDE 500 study was published in the journal Current Medical Research and Opinion.
Wed, Feb 19, 1:50 PM, Zacks
Myriad Genetics Unveils Prolaris Data - Analyst Blog
Shares of Myriad Genetics surged 11.4% at yesterday's market close following the company's recent release of positive data on its Prolaris test.